Global Plasma Fractionation Market Report By Product (Albumin, Immunoglobulins, Coagulation Factor Concentrates, and Others), Application (Neurology, Hematology, Immunology, Critical Care, and Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories And Academic Institutes), And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026
ID:VMR11210047
January 2020
Report Formats:

The growth of the plasma fractionation market can be attributed to the factors such as a rise in the use of prophylactic treatment for immune & bleeding diseases and increased diagnosis rate worldwide. Ongoing growth in geriatric population and increasing use of the alpha-1-antitrypsin and immunoglobulin for various chronic diseases is likely to contribute to the growth of the global plasma fractionation market. Additionally, the rising incidence of the immunological and neurological diseases worldwide along with the increasing use of intravenous immunoglobulin in various therapeutic areas are boosting the growth of the global plasma fractionation market.

According to the Value Market Research, the Global Plasma Fractionation Market is estimated to grow at CAGR 7% from USD 19,875.5 MN in 2017 and reach USD 31,710.5 MN by 2024.
 
IMMUNOGLOBINS TO GAIN THE MOMENTUM
Immunoglobins product segment is the leading segment in 2017 owing to the growing incidence of chronic inflammatory demyelinating polyneuropathy and hypogammaglobulinemia disease coupled with a rise in the use of immunoglobulins to treat Guillain-Barre syndrome, inflammatory myopathies, and specific antibody deficiency disorder. By end of 2024, Immunoglobins is expected to reach USD 14,130.7 MN. In addition, the geriatric population and the emergence of advanced technologies, and enhanced purification techniques are the other key factors that support the growth of the segment. 
 
IMMUNOLOGY EMERGED AS HIGHLY PREFERRED APPLICATION AREA
Immunology is the dominating segment owing to the rising prevalence of immunodeficient disorder across the globe. Immunoglobulin is the most common protein used in blood fraction. Immunoglobulins, also known as antibodies, are glycoprotein molecules released by plasma cells (white blood cells). Basically, they act as a critical part of the immune response by specifically identifying and binding to specific antigens, such as bacteria or viruses, and supporting in their destruction. The high growth of this segment can be attributed to the increasing adoption of plasma products in the treatment of various immunological, neurological, and bleeding disorders.

HOSPITAL & CLINICS TO LEAD THE SEGMENT
The hospitals & clinics end-user segment is dominating in 2017, owing to the increasing adoption of plasma products in the treatment of various immunological, neurological, and bleeding disorders across hospital & clinics. Also, a growing number of the hospital along with an increase in healthcare expenditure is likely to push the growth of the segment uphill. Additionally, owing to the large patient pool treated in hospitals; expansion of hospitals & clinics across the globe along with the increasing number of collaborations between the manufacturers of plasma products and hospitals are again expected to propel the market of plasma fractionation.
 
NORTH AMERICA EMERGED AS THE LARGEST REGION IN THE GLOBAL MARKET FOR PLASMA FRACTIONATION
From the geographical perspective, in 2017, North America held the largest market share in the global plasma fractionation market due to increased use of immunoglobulin in the treatment of neurological diseases coupled with the use of the prophylaxis treatments to diagnosed patients. Moreover, increasing number of hemophilic patients in North America is also expected to boost the market growth in the region.
 
MAJOR COMPETITORS IN MARKET
Baxter International Inc., CSL Limited, Grifols, S.A., Octapharma AG, Bio Products Laboratory Ltd., Kedrion S.P.A., Shire Plc., Shanghai Raas, Hualan Biological Engineering Inc., Biotest AG, China Biologic Products Holdings, Inc., The LFB Group, Sanquin, Japan Blood Products Organization, and Green Cross Corp.

As per this study the global plasma fractionation market was valued at USD XX,XXX.X MN (by revenue) in 2019 and is anticipated to reach USD XX,XXX.X MN by 2026 with a CAGR of X.X%.

Plasma fractionation is a process of extracting various components of blood-derived plasma. It acts as nature’s raw material which is used in dozens of life-saving treatments and medications. The process of plasma fractionation is used to treat protein deficiency disorders in the healthcare sector. The major function of plasma fractionation is to remove or inactivate the virus and prions. Plasma contains various proteins including immunoglobulins, albumin, and clotting proteins such as fibrinogen. Among these albumin constitutes about 60% of the total protein in plasma and is present at concentrations between 35 and 55 mg/ml. It is the key factor responsible to the osmotic pressure of the blood and it functions as a carrier molecule for molecules with low water solubilities such as lipid-soluble hormones, pharmaceutical compounds, enzymes, metal ions, and fatty acids.
 
Market Dynamics
 
Ongoing growth in geriatric population and rising prevalence’s of the immunological and neurological diseases coupled with increasing use of intravenous immunoglobulin in various therapeutic areas are likely to boost the market growth.  In addition, increasing use of the alpha-1-antitrypsin and immunoglobulin for various chronic diseases is further adding impetus growth of the global plasma fractionation market. However, expensive treatment and strict governmental policy are likely to limit the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of plasma fractionation.
 
Market Segmentation
 
The broad plasma fractionation market has been sub-grouped into product, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product Market Share 2019

Plasma Fractionation Market By Product
 
By Product

  • Albumin
  • Immunoglobulins
  • Coagulation Factor Concentrates
  • Others
 
By Application
  • Neurology
  • Hematology
  • Immunology
  • Critical Care
  • Others
 
By End-User
  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for plasma fractionation in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Plasma Fractionation Market By Revenue (USD MN)
 
Europe Plasma Fractionation Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the plasma fractionation market include Baxter International Inc., CSL Limited, Grifols, S.A., Octapharma AG, Bio Products Laboratory Ltd., Kedrion S.P.A., Shire Plc., Shanghai Raas, Hualan Biological Engineering Inc., Biotest AG, China Biologic Products Holdings, Inc., The LFB Group, Sanquin, Japan Blood Products Organization and Green Cross Corp. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Plasma Fractionation Market
       2.2. Global Plasma Fractionation Market Snapshot
 
3 . PLASMA FRACTIONATION – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Plasma Fractionation Market
       3.3. Market Restraints of Plasma Fractionation Market
       3.4. Opportunities of Plasma Fractionation Market
       3.5. Trends of Plasma Fractionation Market
       3.6. Porter’s Five Force Analysis of Plasma Fractionation Market
       3.7. Plasma Fractionation Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by End-User
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Plasma Fractionation Value Chain Analysis
       4.2. Plasma Fractionation Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Plasma Fractionation Raw Material Manufactures List
           4.2.3. Price Trend of Plasma Fractionation Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL PLASMA FRACTIONATION MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Plasma Fractionation Market Analysis by Product
       5.3 Market Analysis of Albumin by Regions
       5.4 Market Analysis of Immunoglobulins by Regions
       5.5 Market Analysis of Coagulation Factor Concentrates by Regions
       5.6 Market Analysis of Others by Regions
 
6 . GLOBAL PLASMA FRACTIONATION MARKET ANALYSIS BY APPLICATION
       6.1 Overview by Application
       6.2 Global Plasma Fractionation Market Analysis by Application
       6.3 Market Analysis of Neurology by Regions
       6.4 Market Analysis of Hematology by Regions
       6.5 Market Analysis of Immunology by Regions
       6.6 Market Analysis of Critical Care by Regions
       6.7 Market Analysis of Others by Regions
 
7 . GLOBAL PLASMA FRACTIONATION MARKET ANALYSIS BY END-USER
       7.1 Overview by End-User
       7.2 Global Plasma Fractionation Market Analysis by End-User
       7.3 Market Analysis of Hospitals and Clinics by Regions
       7.4 Market Analysis of Clinical Research Laboratories by Regions
       7.5 Market Analysis of Academic Institutes by Regions
 
8 . GLOBAL PLASMA FRACTIONATION MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Plasma Fractionation Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Plasma Fractionation Market Estimate by Market Segment
           8.4.3. Europe Plasma Fractionation Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Plasma Fractionation Market Estimate by Market Segment
           8.5.3. Asia Pacific Plasma Fractionation Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Plasma Fractionation Market Estimate by Market Segment
           8.6.3. Latin America Plasma Fractionation Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Plasma Fractionation Market Estimate by Market Segment
           8.7.3. Middle East & Africa Plasma Fractionation Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE PLASMA FRACTIONATION COMPANIES
       9.1. Plasma Fractionation Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF PLASMA FRACTIONATION INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Baxter International Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. CSL Limited
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Grifols, S.A.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Octapharma AG
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Bio Products Laboratory Ltd.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Kedrion S.P.A.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Shire Plc.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Shanghai Raas
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Hualan Biological Engineering Inc.
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Biotest AG
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
       10.13. China Biologic Products Holdings, Inc.
           10.13.1. Company Overview
           10.13.2. Financials
           10.13.3. Products
           10.13.4. Recent Developments
       10.14. The LFB Group
           10.14.1. Company Overview
           10.14.2. Financials
           10.14.3. Products
           10.14.4. Recent Developments
       10.15. Sanquin
           10.15.1. Company Overview
           10.15.2. Financials
           10.15.3. Products
           10.15.4. Recent Developments
       10.16. Japan Blood Products Organization
           10.16.1. Company Overview
           10.16.2. Financials
           10.16.3. Products
           10.16.4. Recent Developments
       10.17. Green Cross Corp.
           10.17.1. Company Overview
           10.17.2. Financials
           10.17.3. Products
           10.17.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES

  •  Global Plasma Fractionation Market Snapshot
  •  Drivers of The Global Plasma Fractionation Market Impact Analysis
  •  Restraints of The Global Plasma Fractionation Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Global Plasma Fractionation Market Analysis by Product (USD MN)
  •  Global Plasma Fractionation Market Analysis in Albumin by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Immunoglobulins by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Coagulation Factor Concentrates by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Others by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis by Application (USD MN)
  •  Global Plasma Fractionation Market Analysis in Neurology by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Hematology by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Immunology by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Critical Care by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Others by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis by End-User (USD MN)
  •  Global Plasma Fractionation Market Analysis in Hospitals and Clinics by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Clinical Research Laboratories by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Academic Institutes by Geography (USD MN)
  •  Global Plasma Fractionation Market by Geography (USD MN)
  •  North America Plasma Fractionation Market Analysis by Product (USD MN)
  •  North America Plasma Fractionation Market Estimate by Application (USD MN)
  •  North America Plasma Fractionation Market Estimate by End-User (USD MN)
  •  North America Plasma Fractionation Market Estimate by Country (USD MN)
  •  United State Plasma Fractionation Market Analysis by Product (USD MN)
  •  United State Plasma Fractionation Market Estimate by Application (USD MN)
  •  United State Plasma Fractionation Market Analysis by End-User (USD MN)
  •  Rest of North America Plasma Fractionation Market Analysis by Product (USD MN)
  •  Rest of North America Plasma Fractionation Market Estimate by Application (USD MN)
  •  Rest of North America Plasma Fractionation Market Estimate by End-User(USD MN)
  •  Europe Plasma Fractionation Market Analysis by Product (USD MN)
  •  Europe Plasma Fractionation Market Estimate by Application (USD MN)
  •  Europe Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Europe Plasma Fractionation Market Estimate by 38 (USD MN)
  •  United Kingdom Plasma Fractionation Market Analysis by Product (USD MN)
  •  United Kingdom Plasma Fractionation Market Estimate by Application (USD MN)
  •  United Kingdom Plasma Fractionation Market Estimate by End-User (USD MN)
  •  France Plasma Fractionation Market Analysis by Product (USD MN)
  •  France Plasma Fractionation Market Estimate by Application (USD MN)
  •  France Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Germany Plasma Fractionation Market Analysis by Product (USD MN)
  •  Germany Plasma Fractionation Market Estimate by Application (USD MN)
  •  Germany Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Rest of Europe Plasma Fractionation Market Analysis by Product (USD MN)
  •  Rest of Europe Plasma Fractionation Market Estimate by Application (USD MN)
  •  Rest of Europe Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Asia Pacific Plasma Fractionation Market Analysis by Product (USD MN)
  •  Asia Pacific Plasma Fractionation Market Estimate by Application (USD MN)
  •  Asia Pacific Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Asia Pacific Plasma Fractionation Market Estimate by Country (USD MN)
  •  China Plasma Fractionation Market Analysis by Product (USD MN)
  •  China Plasma Fractionation Market Estimate by Application (USD MN)
  •  China Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Japan Plasma Fractionation Market Analysis by Product (USD MN)
  •  Japan Plasma Fractionation Market Estimate by Application (USD MN)
  •  Japan Plasma Fractionation Market Estimate by End-User (USD MN)
  •  India Plasma Fractionation Market Analysis by Product (USD MN)
  •  India Plasma Fractionation Market Estimate by Application (USD MN)
  •  India Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Rest of Asia Pacific Plasma Fractionation Market Analysis by Product (USD MN)
  •  Rest of Asia Pacific Plasma Fractionation Market Estimate by Application (USD MN)
  •  Rest of Asia Pacific Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Latin America Plasma Fractionation Market Analysis by Product (USD MN)
  •  Latin America Plasma Fractionation Market Estimate by Application (USD MN)
  •  Latin America Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Latin America Plasma Fractionation Market Estimate by Country (USD MN)
  •  Brazil Plasma Fractionation Market Analysis by Product (USD MN)
  •  Brazil Plasma Fractionation Market Estimate by Application (USD MN)
  •  Brazil Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Rest of Latin America Plasma Fractionation Market Analysis by Product (USD MN)
  •  Rest of Latin America Plasma Fractionation Market Estimate by Application (USD MN)
  •  Rest of Latin America Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Middle East & Africa Plasma Fractionation Market Analysis by Product (USD MN)
  •  Middle East & Africa Plasma Fractionation Market Estimate by Application (USD MN)
  •  Middle East & Africa Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Middle East & Africa Plasma Fractionation Market Estimate by Country (USD MN)
  •  Middle East Plasma Fractionation Market Analysis by Product (USD MN)
  •  Middle East Plasma Fractionation Market Estimate by Application (USD MN)
  •  Middle East Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Africa Plasma Fractionation Market Analysis by Product (USD MN)
  •  Africa Plasma Fractionation Market Estimate by Application (USD MN)
  •  Africa Plasma Fractionation Market Estimate by End-User (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
  •  Research Scope of Plasma Fractionation Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Plasma Fractionation Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by End-User
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Plasma Fractionation Market Analysis by Product (USD MN)
  •  Global Plasma Fractionation Market Analysis in Albumin by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Immunoglobulins by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Coagulation Factor Concentrates by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Others by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis by Application (USD MN)
  •  Global Plasma Fractionation Market Analysis in Neurology by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Hematology by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Immunology by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Critical Care by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Others by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis by End-User (USD MN)
  •  Global Plasma Fractionation Market Analysis in Hospitals and Clinics by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Clinical Research Laboratories by Geography (USD MN)
  •  Global Plasma Fractionation Market Analysis in Academic Institutes by Geography (USD MN)
  •  Latin America Plasma Fractionation Market by Revenue
  •  Middle East & Africa Plasma Fractionation Market by Revenue
  •  Recent Development in Plasma Fractionation Industry
  •  Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials